Inno-LIA HIV i/II score
Ended Purchase Order Awarded Last action
- Contract number
- 75D30123P17195
- Awardee
-
Fujirebio US, Inc. UEI QLBVMG7KJ3W5
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $24,070
Award facts
- Contract value 100% obligated
- $24,069.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Atlanta, GA 30341, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $24,069.52 purchase order to Fujirebio US, Inc. for INNO-LIA HIV I/II SCORE tests. Fujirebio US, Inc. will deliver the tests from its division location in Chamblee, Georgia under the firm fixed price contract, which runs from July 20 through September 30, 2023. No set aside designation or subcontractors were indicated. The Centers for Disease Control and Prevention works to protect public health and safety through global disease prevention, and this contract supports their efforts to combat HIV/AIDS with diagnostic testing materials.
Quick answers
Who was awarded contract 75D30123P17195?
75D30123P17195 was awarded to Fujirebio US, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on July 20, 2023.
How much is contract 75D30123P17195 worth?
The government has obligated $24,070 on 75D30123P17195.
Was contract 75D30123P17195 competed?
The extent of competition for 75D30123P17195 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award